This site uses cookies as described in our Cookie Policy. To see what cookies we serve, please check our Cookie Settings Panel. I agree with this cookie policy, don't show this message again
Blog

Published on

Check out the on-demand symposium recording from the European Respiratory Society congress 2020 by clicking here. Learn how C-reactive protein (CRP) point-of-care testing can be a valuable diagnostic and clinical decision-making tool in relation to COVID-19, and how it may also inform antibiotic prescribing for acutely exacerbated chronic obstructive pulmonary disease (COPD) patients.

Learn about the value of CRP point-of-care testing for COPD and antimicrobial in the context of COVID-19

en
Share
Like
Tweet

The European Respiratory Society congress (ERS) was held on 7–9 September 2020 and delivered the latest innovations in respiratory medicine to over 33,000 delegates.

myPOCacademy hosted a virtual symposium covering CRP point-of-care testing in the time of COVID-19 and for the reduction of antibiotic prescribing in acutely exacerbated COPD patients, watched live by nearly 500 healthcare professionals.

Hear expert perspectives on the value of C-reactive protein (CRP) point-of-care testing (POCT) in the context of COVID-19 by watching the on-demand symposium recording which is now available exclusively on myPOCacademy.

Featuring expert opinion from front-line healthcare staff from around the world, discussions centered around the following topics:

  • CRP level as an inflammatory marker for severity and risk assessment in COVID-19
  • CRP POCT for identification of patients at high risk of severe outcomes in COVID-19
  • CRP POCT for optimal allocation of hospital and intensive care unit resources
  • CRP POCT to aid clinical decision-making and guide antibiotic prescribing in patients presenting with symptoms of respiratory tract infections
  • The role of CRP POCT in the fight against anti-microbial resistance
  • CRP POCT as a diagnostic strategy in patients presenting with acute exacerbation of chronic obstructive pulmonary disease (COPD) in primary care (the PACE study)

Click here to watch the ERS symposium recording in full.

© 2024 Abbott. All rights reserved. All trademarks referenced are trademarks of either the Abbott group of companies or their respective owners.

Related News

Cards

"-- SEO4AJAX --" "seo4ajax Access"

"-- SEO4AJAX --" "Init" {"hubsSlug":"mypocacademy","regionsSlug":"ww","languagesSlug":"en","newsSlug":"you-can-now-watch-the-symposium-crp-point-of-care-testing-in-the-time-of-covid-19-and-for-the-reduction-of-antibiotic-prescribing-in-acutely-exacerbated-copd-patients-on-demand"}

"-- SEO4AJAX --" "Normalization A" {"hubsSlug":"mypocacademy","regionsSlug":"ww","languagesSlug":"en","newsSlug":"you-can-now-watch-the-symposium-crp-point-of-care-testing-in-the-time-of-covid-19-and-for-the-reduction-of-antibiotic-prescribing-in-acutely-exacerbated-copd-patients-on-demand"} 200 "https://campus.meplis.com/mypocacademy/ww/en/news/you-can-now-watch-the-symposium-crp-point-of-care-testing-in-the-time-of-covid-19-and-for-the-reduction-of-antibiotic-prescribing-in-acutely-exacerbated-copd-patients-on-demand"

"-- SEO4AJAX --" "Normalization B" {"hubsSlug":"mypocacademy","regionsSlug":"ww","languagesSlug":"en","newsSlug":"you-can-now-watch-the-symposium-crp-point-of-care-testing-in-the-time-of-covid-19-and-for-the-reduction-of-antibiotic-prescribing-in-acutely-exacerbated-copd-patients-on-demand"} 200 "https://campus.meplis.com/mypocacademy/ww/en/news/you-can-now-watch-the-symposium-crp-point-of-care-testing-in-the-time-of-covid-19-and-for-the-reduction-of-antibiotic-prescribing-in-acutely-exacerbated-copd-patients-on-demand"

"-- SEO4AJAX --" "Timeout: " 5 " seconds"

"-- SEO4AJAX --" "$window.onCaptureReady Called" 200 "https://campus.meplis.com/mypocacademy/ww/en/news/you-can-now-watch-the-symposium-crp-point-of-care-testing-in-the-time-of-covid-19-and-for-the-reduction-of-antibiotic-prescribing-in-acutely-exacerbated-copd-patients-on-demand"

"-- SEO4AJAX --" "Bugsnag Called"